Nurx cream review: 45 g tretinoin tubes and the separate ReviveRx bottle

The treatment page lists tretinoin cream at 0.025%, 0.05% and 0.1%, each with a 45 g tube description. ReviveRx appears on a separate card as a 26 mL bottle. Keeping those presentations distinct prevents the familiar tretinoin name from hiding the fact that one option is an explicitly named multi-ingredient compound. Nurx treatment page

These are advertised package descriptions, rather than a report of examining what Nurx delivered. A provider determines the treatment after consultation. The RedBox preparation review offers another place to read about a published tube quantity, while the strength and vehicle guide separates that quantity from concentration. Nurx treatment page

ReviveRx’s card lists azelaic acid at 10%, niacinamide at 4% and tretinoin at one of three published strengths. A later introduction adds hyaluronic acid and ceramides to the description. These details give the named combination a clearer identity than a general promise of customized skincare, but they do not identify every component of its base. Nurx treatment page

Nor should the advertised strengths be read as choices for a person to make independently. The record must correspond to the prescription selected after assessment. The Hims cream review provides a different combination record to compare, without assuming that shared active names establish matching bases, doses or finished-product results. Nurx treatment page

The plain tretinoin cards disclose cream, strength and tube quantity, but the reviewed descriptions do not identify the manufacturer of an individual supply or give that product’s entire inactive list. Those are meaningful missing fields. Knowing the active and tube size is more precise than a generic service name, while still falling short of a complete formulation. Nurx treatment page

The RETIN-A label illustrates the difference: it names a hydrophilic cream vehicle and separately describes an alcohol-containing gel. Those details belong to the labeled products. They cannot complete an unidentified Nurx tube or ReviveRx’s base. The dispensing-record guide follows the record that would connect a chosen product to its actual preparation. RETIN-A label

The product cards show $90 charged for a three-month medication supply, alongside $30 per month. The separate cost FAQ also identifies a $30 consultation and $90 medication charge, automatic refills and free shipping. These statements describe medication and consultation charges; they do not turn the monthly figure into a complete individualized quote. Nurx treatment page Nurx cost FAQ

The treatment page adds a $3 support fee in a month when one or more orders are processed. Its stated coverage is customer care and certain processing fees. Year-long medical-team messaging is described separately. The page also qualifies prices and additional charges. Keeping those roles separate avoids calling a customer-care fee proof of a clinical service or response. Nurx treatment page

Nurx describes evaluation by a provider licensed in the patient’s state, followed by a prescription when clinically appropriate. Its FAQ says its pharmacy fills the prescription and sends the medication. The service also advertises unlimited provider messaging. None of this establishes that a particular formula was selected or a particular pharmacy supplied it to this publication. Nurx treatment page

The page says services are not available in every state and describes images as illustrative. Those qualifications belong with the convenient-delivery narrative. FDA’s pharmacist guidance recognizes that website, prescription and pharmacy information can differ. It supports clarification of the actual record; it does not verify an order, observed communication or pharmacy arrangement here. Nurx treatment page FDA pharmacist guidance

The ReviveRx card expressly identifies an Rx-only compound that is not FDA-approved. The later introduction describes its tretinoin as FDA-approved. The important distinction is between the ingredient or approved product reference and this finished combination. It would be inaccurate to drop the card’s nonapproval disclosure while adopting the later phrase as approval of ReviveRx. Nurx treatment page

FDA distinguishes compounds from approved drugs, including approved generics. That explanation does not determine which generic tube an individual would receive, and it does not measure the ReviveRx mixture’s effects. The combination-ingredient article likewise separates an ingredient rationale from evidence about the entire supplied preparation. FDA compounding explanation

Nurx’s positive documentary detail is the clear separation of a 45 g cream tube and a 26 mL combination bottle. The public records also distinguish medication, consultation and support charges. The next unanswered preparation question is which complete formulation and manufacturer or compounder matches the medicine selected by the provider. Nurx treatment page

Neither automatic refill wording nor a three-month commercial description supplies dating for the actual container. FDA’s stability explanation concerns the product and its labeled conditions. The container article keeps those fields attached to the relevant record, without deriving storage instructions or a lifetime from a service’s billing period. Nurx cost FAQ FDA stability explanation